Over 50 hospitals, including private and government hospitals, have a shortage of ICU and ventilator beds, as per the government data till 5 pm on Sunday.
At least 447 cases of adverse effects post-vaccination
In the last 24 hours, 15,144 daily cases were recorded, taking the total number of cases to 10.56 million.Premium
1 min read
Share Via
Read Full Story
At least 447 people reported adverse effects after receiving covid-19 vaccination, with the majority complaining of fever, headache, and nausea, according to the provisional data released on Sunday.
These are classed as adverse event following immunization (AEFI) and may not necessarily be related to the vaccine or the vaccination process.
TRENDING STORIESSee All
1 min read
Premium
1 min read
Premium
2 min read
Premium
1 min read
. 01:20 PM IST
Mass immunization began as infections continued to rise. In the last 24 hours, 15,144 daily cases were recorded, taking the total number of cases to 10.56 million, while the toll mounted to more than 153,00. Active cases numbered more than 208,000 on Sunday.
Over 2.24 lakh get vaccine so far; 447 adverse effect cases
Over 2.24 lakh get vaccine so far; 447 adverse effect cases
Bangalore Mirror Bureau / Updated: Jan 18, 2021, 06:00 IST
A medical worker waits beore being inoculated with a Covid-19 vaccine at Gangaram hospital in New Delhi
A total of 2,24,301 beneficiaries have been inoculated with COVID-19 vaccine so far, out of which only 447 adverse events following immunisation (AEFI) were reported, the
Union Health Ministry said on day two of the nationwide vaccination drive on Sunday.
Addressing a press briefing, the ministry’s Additional Secretary Manohar Agnani said out of the 447 adverse events following immunisation, only three required hospitalisation.
Representative image (AP)
NEW DELHI: A total of 447 adverse events following immunisation against Covid-19 were reported during the first two days of the vaccination drive. While only three cases were initially hospitalised, two have already been discharged from AIIMS, New Delhi, and the Northern Railway Hospital, respectively, the health ministry said. “One case is still under observation in AIIMS Rishikesh and is fine,” additional health secretary Manohar Agnani said.
Most of the adverse events reported so far are minor like fever, pain, headache, nau-sea, giddiness and mild allergic reactions like rashes etc. “Protocols are in place for reporting, immediate case management at vaccination session site, transportation and hospitalisation and further care of such cases. Protocols are in place for systematic investigation and causality assessment of serious AEFIs,” Agnani said. A worker in AIIMS was hospitalised after he developed an allergic reaction after getting a Covaxi
India has approved for emergency use Covaxin developed by Bharat Biotech and Covishield from the Oxford/AstraZeneca stable and manufactured by the Serum Institute of India.